0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Heparin Market Insights and Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Auto-12130
Home | Market Reports | Health | Health Conditions | Heart & Hypertension
Global Heparin Market Insights and Forecast to 2028

Global Heparin Market Insights and Forecast to 2028

Code: QYRE-Auto-12130
Report
January 2022
112 Pages
QYResearch
Region: Global, Europe, China,
Description
Table of Content
Tables & Figures
Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. This report is revolving around Heparin Active Pharmaceutical Ingredients (API).
Market Analysis and Insights: Global Heparin Market

Due to the COVID-19 pandemic, the global Heparin market size is estimated to be worth US$ 2839.7 million in 2022 and is forecast to a readjusted size of US$ 7359.3 million by 2028 with a CAGR of 17.2% during the review period.

Fully considering the economic change by this health crisis, Heparin Sodium Raw Material Drug accounting for % of the Heparin global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Low Molecular Weight Heparin Preparation segment is altered to an % CAGR throughout this forecast period.
Global Heparin key players include Hepalink, Bioibérica, Pfizer, King-friend Biochemical Pharmaceutical, Jiulong Biochemicals, etc. Global top five manufacturers hold a share about 55%. Europe is the largest market, with a share about 40%, followed by USA, with a share about 35 percent. In terms of product, Heparin Sodium Raw Material Drug is the largest segment, with a share about 96%. And in terms of application, the largest application is Low Molecular Weight Heparin Preparation, followed by Standard Heparin Preparation.
In terms of production side, this report researches the Heparin capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Heparin by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Heparin Scope and Segment
Heparin market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Heparin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Heparin Sodium Raw Material Drug
Heparin Calcium Raw Material Drug

Segment by Application

Low Molecular Weight Heparin Preparation
Standard Heparin Preparation

BY COMPANY

Hepalink
Changshan Pharm
Qianhong Bio-pharma
Opocrin
Pfizer
Aspen Oss
King-friend Biochemical Pharmaceutical
Bioibérica
Dongcheng Biochemicals
Jiulong Biochemicals
Tiandong
Xinbai
Yino Pharma
Deebio

Production by Region

North America
Europe
China
Mexico

Consumption by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
1 Study Coverage
1.1 Heparin Product Introduction
1.2 Market by Type
1.2.1 Global Heparin Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Heparin Sodium Raw Material Drug
1.2.3 Heparin Calcium Raw Material Drug
1.3 Market by Application
1.3.1 Global Heparin Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Low Molecular Weight Heparin Preparation
1.3.3 Standard Heparin Preparation
1.4 Study Objectives
1.5 Years Considered
2 Global Heparin Production
2.1 Global Heparin Production Capacity (2017-2028)
2.2 Global Heparin Production by Region: 2017 VS 2021 VS 2028
2.3 Global Heparin Production by Region
2.3.1 Global Heparin Historic Production by Region (2017-2022)
2.3.2 Global Heparin Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Mexico
3 Global Heparin Sales in Volume & Value Estimates and Forecasts
3.1 Global Heparin Sales Estimates and Forecasts 2017-2028
3.2 Global Heparin Revenue Estimates and Forecasts 2017-2028
3.3 Global Heparin Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Heparin Sales by Region
3.4.1 Global Heparin Sales by Region (2017-2022)
3.4.2 Global Sales Heparin by Region (2023-2028)
3.5 Global Heparin Revenue by Region
3.5.1 Global Heparin Revenue by Region (2017-2022)
3.5.2 Global Heparin Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Heparin Production Capacity by Manufacturers
4.2 Global Heparin Sales by Manufacturers
4.2.1 Global Heparin Sales by Manufacturers (2017-2022)
4.2.2 Global Heparin Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Heparin in 2021
4.3 Global Heparin Revenue by Manufacturers
4.3.1 Global Heparin Revenue by Manufacturers (2017-2022)
4.3.2 Global Heparin Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Heparin Revenue in 2021
4.4 Global Heparin Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Heparin Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Heparin Sales by Type
5.1.1 Global Heparin Historical Sales by Type (2017-2022)
5.1.2 Global Heparin Forecasted Sales by Type (2023-2028)
5.1.3 Global Heparin Sales Market Share by Type (2017-2028)
5.2 Global Heparin Revenue by Type
5.2.1 Global Heparin Historical Revenue by Type (2017-2022)
5.2.2 Global Heparin Forecasted Revenue by Type (2023-2028)
5.2.3 Global Heparin Revenue Market Share by Type (2017-2028)
5.3 Global Heparin Price by Type
5.3.1 Global Heparin Price by Type (2017-2022)
5.3.2 Global Heparin Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Heparin Sales by Application
6.1.1 Global Heparin Historical Sales by Application (2017-2022)
6.1.2 Global Heparin Forecasted Sales by Application (2023-2028)
6.1.3 Global Heparin Sales Market Share by Application (2017-2028)
6.2 Global Heparin Revenue by Application
6.2.1 Global Heparin Historical Revenue by Application (2017-2022)
6.2.2 Global Heparin Forecasted Revenue by Application (2023-2028)
6.2.3 Global Heparin Revenue Market Share by Application (2017-2028)
6.3 Global Heparin Price by Application
6.3.1 Global Heparin Price by Application (2017-2022)
6.3.2 Global Heparin Price Forecast by Application (2023-2028)
7 North America
7.1 North America Heparin Market Size by Type
7.1.1 North America Heparin Sales by Type (2017-2028)
7.1.2 North America Heparin Revenue by Type (2017-2028)
7.2 North America Heparin Market Size by Application
7.2.1 North America Heparin Sales by Application (2017-2028)
7.2.2 North America Heparin Revenue by Application (2017-2028)
7.3 North America Heparin Sales by Country
7.3.1 North America Heparin Sales by Country (2017-2028)
7.3.2 North America Heparin Revenue by Country (2017-2028)
7.3.3 U.S.
7.3.4 Canada
8 Europe
8.1 Europe Heparin Market Size by Type
8.1.1 Europe Heparin Sales by Type (2017-2028)
8.1.2 Europe Heparin Revenue by Type (2017-2028)
8.2 Europe Heparin Market Size by Application
8.2.1 Europe Heparin Sales by Application (2017-2028)
8.2.2 Europe Heparin Revenue by Application (2017-2028)
8.3 Europe Heparin Sales by Country
8.3.1 Europe Heparin Sales by Country (2017-2028)
8.3.2 Europe Heparin Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Heparin Market Size by Type
9.1.1 Asia Pacific Heparin Sales by Type (2017-2028)
9.1.2 Asia Pacific Heparin Revenue by Type (2017-2028)
9.2 Asia Pacific Heparin Market Size by Application
9.2.1 Asia Pacific Heparin Sales by Application (2017-2028)
9.2.2 Asia Pacific Heparin Revenue by Application (2017-2028)
9.3 Asia Pacific Heparin Sales by Region
9.3.1 Asia Pacific Heparin Sales by Region (2017-2028)
9.3.2 Asia Pacific Heparin Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
9.3.12 Philippines
10 Latin America
10.1 Latin America Heparin Market Size by Type
10.1.1 Latin America Heparin Sales by Type (2017-2028)
10.1.2 Latin America Heparin Revenue by Type (2017-2028)
10.2 Latin America Heparin Market Size by Application
10.2.1 Latin America Heparin Sales by Application (2017-2028)
10.2.2 Latin America Heparin Revenue by Application (2017-2028)
10.3 Latin America Heparin Sales by Country
10.3.1 Latin America Heparin Sales by Country (2017-2028)
10.3.2 Latin America Heparin Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Heparin Market Size by Type
11.1.1 Middle East and Africa Heparin Sales by Type (2017-2028)
11.1.2 Middle East and Africa Heparin Revenue by Type (2017-2028)
11.2 Middle East and Africa Heparin Market Size by Application
11.2.1 Middle East and Africa Heparin Sales by Application (2017-2028)
11.2.2 Middle East and Africa Heparin Revenue by Application (2017-2028)
11.3 Middle East and Africa Heparin Sales by Country
11.3.1 Middle East and Africa Heparin Sales by Country (2017-2028)
11.3.2 Middle East and Africa Heparin Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 U.A.E
12 Corporate Profiles
12.1 Hepalink
12.1.1 Hepalink Corporation Information
12.1.2 Hepalink Overview
12.1.3 Hepalink Heparin Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Hepalink Heparin Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Hepalink Recent Developments
12.2 Changshan Pharm
12.2.1 Changshan Pharm Corporation Information
12.2.2 Changshan Pharm Overview
12.2.3 Changshan Pharm Heparin Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Changshan Pharm Heparin Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Changshan Pharm Recent Developments
12.3 Qianhong Bio-pharma
12.3.1 Qianhong Bio-pharma Corporation Information
12.3.2 Qianhong Bio-pharma Overview
12.3.3 Qianhong Bio-pharma Heparin Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Qianhong Bio-pharma Heparin Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Qianhong Bio-pharma Recent Developments
12.4 Opocrin
12.4.1 Opocrin Corporation Information
12.4.2 Opocrin Overview
12.4.3 Opocrin Heparin Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Opocrin Heparin Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Opocrin Recent Developments
12.5 Pfizer
12.5.1 Pfizer Corporation Information
12.5.2 Pfizer Overview
12.5.3 Pfizer Heparin Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Pfizer Heparin Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Pfizer Recent Developments
12.6 Aspen Oss
12.6.1 Aspen Oss Corporation Information
12.6.2 Aspen Oss Overview
12.6.3 Aspen Oss Heparin Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Aspen Oss Heparin Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Aspen Oss Recent Developments
12.7 King-friend Biochemical Pharmaceutical
12.7.1 King-friend Biochemical Pharmaceutical Corporation Information
12.7.2 King-friend Biochemical Pharmaceutical Overview
12.7.3 King-friend Biochemical Pharmaceutical Heparin Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 King-friend Biochemical Pharmaceutical Heparin Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 King-friend Biochemical Pharmaceutical Recent Developments
12.8 Bioibérica
12.8.1 Bioibérica Corporation Information
12.8.2 Bioibérica Overview
12.8.3 Bioibérica Heparin Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Bioibérica Heparin Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Bioibérica Recent Developments
12.9 Dongcheng Biochemicals
12.9.1 Dongcheng Biochemicals Corporation Information
12.9.2 Dongcheng Biochemicals Overview
12.9.3 Dongcheng Biochemicals Heparin Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Dongcheng Biochemicals Heparin Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Dongcheng Biochemicals Recent Developments
12.10 Jiulong Biochemicals
12.10.1 Jiulong Biochemicals Corporation Information
12.10.2 Jiulong Biochemicals Overview
12.10.3 Jiulong Biochemicals Heparin Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Jiulong Biochemicals Heparin Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Jiulong Biochemicals Recent Developments
12.11 Tiandong
12.11.1 Tiandong Corporation Information
12.11.2 Tiandong Overview
12.11.3 Tiandong Heparin Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 Tiandong Heparin Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Tiandong Recent Developments
12.12 Xinbai
12.12.1 Xinbai Corporation Information
12.12.2 Xinbai Overview
12.12.3 Xinbai Heparin Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 Xinbai Heparin Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Xinbai Recent Developments
12.13 Yino Pharma
12.13.1 Yino Pharma Corporation Information
12.13.2 Yino Pharma Overview
12.13.3 Yino Pharma Heparin Sales, Price, Revenue and Gross Margin (2017-2022)
12.13.4 Yino Pharma Heparin Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Yino Pharma Recent Developments
12.14 Deebio
12.14.1 Deebio Corporation Information
12.14.2 Deebio Overview
12.14.3 Deebio Heparin Sales, Price, Revenue and Gross Margin (2017-2022)
12.14.4 Deebio Heparin Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 Deebio Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Heparin Industry Chain Analysis
13.2 Heparin Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Heparin Production Mode & Process
13.4 Heparin Sales and Marketing
13.4.1 Heparin Sales Channels
13.4.2 Heparin Distributors
13.5 Heparin Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Heparin Industry Trends
14.2 Heparin Market Drivers
14.3 Heparin Market Challenges
14.4 Heparin Market Restraints
15 Key Finding in The Global Heparin Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
    Table 1. Global Heparin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Heparin Sodium Raw Material Drug
    Table 3. Major Manufacturers of Heparin Calcium Raw Material Drug
    Table 4. Global Heparin Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
    Table 5. Global Heparin Production by Region: 2017 VS 2021 VS 2028 (B Units)
    Table 6. Global Heparin Production by Region (2017-2022) & (B Units)
    Table 7. Global Heparin Production Market Share by Region (2017-2022)
    Table 8. Global Heparin Production by Region (2023-2028) & (B Units)
    Table 9. Global Heparin Production Market Share by Region (2023-2028)
    Table 10. Global Heparin Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 11. Global Heparin Sales by Region (2017-2022) & (B Units)
    Table 12. Global Heparin Sales Market Share by Region (2017-2022)
    Table 13. Global Heparin Sales by Region (2023-2028) & (B Units)
    Table 14. Global Heparin Sales Market Share by Region (2023-2028)
    Table 15. Global Heparin Revenue by Region (2017-2022) & (US$ Million)
    Table 16. Global Heparin Revenue Market Share by Region (2017-2022)
    Table 17. Global Heparin Revenue by Region (2023-2028) & (US$ Million)
    Table 18. Global Heparin Revenue Market Share by Region (2023-2028)
    Table 19. Global Heparin Production Capacity by Manufacturers (2017-2022) & (B Units)
    Table 20. Global Heparin Capacity Market Share by Manufacturers (2017-2022)
    Table 21. Global Heparin Sales by Manufacturers (2017-2022) & (B Units)
    Table 22. Global Heparin Sales Market Share by Manufacturers (2017-2022)
    Table 23. Global Heparin Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 24. Global Heparin Revenue Share by Manufacturers (2017-2022)
    Table 25. Heparin Price by Manufacturers 2017-2022 (USD/Unit)
    Table 26. Global Heparin Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 27. Global Heparin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin as of 2021)
    Table 28. Heparin Manufacturing Base Distribution and Headquarters
    Table 29. Manufacturers Heparin Product Offered
    Table 30. Date of Manufacturers Enter into Heparin Market
    Table 31. Mergers & Acquisitions, Expansion Plans
    Table 32. Global Heparin Sales by Type (2017-2022) & (B Units)
    Table 33. Global Heparin Sales by Type (2023-2028) & (B Units)
    Table 34. Global Heparin Sales Share by Type (2017-2022)
    Table 35. Global Heparin Sales Share by Type (2023-2028)
    Table 36. Global Heparin Revenue by Type (2017-2022) & (US$ Million)
    Table 37. Global Heparin Revenue by Type (2023-2028) & (US$ Million)
    Table 38. Global Heparin Revenue Share by Type (2017-2022)
    Table 39. Global Heparin Revenue Share by Type (2023-2028)
    Table 40. Heparin Price by Type (2017-2022) & (USD/Unit)
    Table 41. Global Heparin Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 42. Global Heparin Sales by Application (2017-2022) & (B Units)
    Table 43. Global Heparin Sales by Application (2023-2028) & (B Units)
    Table 44. Global Heparin Sales Share by Application (2017-2022)
    Table 45. Global Heparin Sales Share by Application (2023-2028)
    Table 46. Global Heparin Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Heparin Revenue by Application (2023-2028) & (US$ Million)
    Table 48. Global Heparin Revenue Share by Application (2017-2022)
    Table 49. Global Heparin Revenue Share by Application (2023-2028)
    Table 50. Heparin Price by Application (2017-2022) & (USD/Unit)
    Table 51. Global Heparin Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 52. North America Heparin Sales by Type (2017-2022) & (B Units)
    Table 53. North America Heparin Sales by Type (2023-2028) & (B Units)
    Table 54. North America Heparin Revenue by Type (2017-2022) & (US$ Million)
    Table 55. North America Heparin Revenue by Type (2023-2028) & (US$ Million)
    Table 56. North America Heparin Sales by Application (2017-2022) & (B Units)
    Table 57. North America Heparin Sales by Application (2023-2028) & (B Units)
    Table 58. North America Heparin Revenue by Application (2017-2022) & (US$ Million)
    Table 59. North America Heparin Revenue by Application (2023-2028) & (US$ Million)
    Table 60. North America Heparin Sales by Country (2017-2022) & (B Units)
    Table 61. North America Heparin Sales by Country (2023-2028) & (B Units)
    Table 62. North America Heparin Revenue by Country (2017-2022) & (US$ Million)
    Table 63. North America Heparin Revenue by Country (2023-2028) & (US$ Million)
    Table 64. Europe Heparin Sales by Type (2017-2022) & (B Units)
    Table 65. Europe Heparin Sales by Type (2023-2028) & (B Units)
    Table 66. Europe Heparin Revenue by Type (2017-2022) & (US$ Million)
    Table 67. Europe Heparin Revenue by Type (2023-2028) & (US$ Million)
    Table 68. Europe Heparin Sales by Application (2017-2022) & (B Units)
    Table 69. Europe Heparin Sales by Application (2023-2028) & (B Units)
    Table 70. Europe Heparin Revenue by Application (2017-2022) & (US$ Million)
    Table 71. Europe Heparin Revenue by Application (2023-2028) & (US$ Million)
    Table 72. Europe Heparin Sales by Country (2017-2022) & (B Units)
    Table 73. Europe Heparin Sales by Country (2023-2028) & (B Units)
    Table 74. Europe Heparin Revenue by Country (2017-2022) & (US$ Million)
    Table 75. Europe Heparin Revenue by Country (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Heparin Sales by Type (2017-2022) & (B Units)
    Table 77. Asia Pacific Heparin Sales by Type (2023-2028) & (B Units)
    Table 78. Asia Pacific Heparin Revenue by Type (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Heparin Revenue by Type (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Heparin Sales by Application (2017-2022) & (B Units)
    Table 81. Asia Pacific Heparin Sales by Application (2023-2028) & (B Units)
    Table 82. Asia Pacific Heparin Revenue by Application (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Heparin Revenue by Application (2023-2028) & (US$ Million)
    Table 84. Asia Pacific Heparin Sales by Region (2017-2022) & (B Units)
    Table 85. Asia Pacific Heparin Sales by Region (2023-2028) & (B Units)
    Table 86. Asia Pacific Heparin Revenue by Region (2017-2022) & (US$ Million)
    Table 87. Asia Pacific Heparin Revenue by Region (2023-2028) & (US$ Million)
    Table 88. Latin America Heparin Sales by Type (2017-2022) & (B Units)
    Table 89. Latin America Heparin Sales by Type (2023-2028) & (B Units)
    Table 90. Latin America Heparin Revenue by Type (2017-2022) & (US$ Million)
    Table 91. Latin America Heparin Revenue by Type (2023-2028) & (US$ Million)
    Table 92. Latin America Heparin Sales by Application (2017-2022) & (B Units)
    Table 93. Latin America Heparin Sales by Application (2023-2028) & (B Units)
    Table 94. Latin America Heparin Revenue by Application (2017-2022) & (US$ Million)
    Table 95. Latin America Heparin Revenue by Application (2023-2028) & (US$ Million)
    Table 96. Latin America Heparin Sales by Country (2017-2022) & (B Units)
    Table 97. Latin America Heparin Sales by Country (2023-2028) & (B Units)
    Table 98. Latin America Heparin Revenue by Country (2017-2022) & (US$ Million)
    Table 99. Latin America Heparin Revenue by Country (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Heparin Sales by Type (2017-2022) & (B Units)
    Table 101. Middle East and Africa Heparin Sales by Type (2023-2028) & (B Units)
    Table 102. Middle East and Africa Heparin Revenue by Type (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Heparin Revenue by Type (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Heparin Sales by Application (2017-2022) & (B Units)
    Table 105. Middle East and Africa Heparin Sales by Application (2023-2028) & (B Units)
    Table 106. Middle East and Africa Heparin Revenue by Application (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Heparin Revenue by Application (2023-2028) & (US$ Million)
    Table 108. Middle East and Africa Heparin Sales by Country (2017-2022) & (B Units)
    Table 109. Middle East and Africa Heparin Sales by Country (2023-2028) & (B Units)
    Table 110. Middle East and Africa Heparin Revenue by Country (2017-2022) & (US$ Million)
    Table 111. Middle East and Africa Heparin Revenue by Country (2023-2028) & (US$ Million)
    Table 112. Hepalink Corporation Information
    Table 113. Hepalink Description and Major Businesses
    Table 114. Hepalink Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 115. Hepalink Heparin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Hepalink Recent Development
    Table 117. Changshan Pharm Corporation Information
    Table 118. Changshan Pharm Description and Major Businesses
    Table 119. Changshan Pharm Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 120. Changshan Pharm Heparin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Changshan Pharm Recent Development
    Table 122. Qianhong Bio-pharma Corporation Information
    Table 123. Qianhong Bio-pharma Description and Major Businesses
    Table 124. Qianhong Bio-pharma Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 125. Qianhong Bio-pharma Heparin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Qianhong Bio-pharma Recent Development
    Table 127. Opocrin Corporation Information
    Table 128. Opocrin Description and Major Businesses
    Table 129. Opocrin Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 130. Opocrin Heparin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Opocrin Recent Development
    Table 132. Pfizer Corporation Information
    Table 133. Pfizer Description and Major Businesses
    Table 134. Pfizer Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 135. Pfizer Heparin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Pfizer Recent Development
    Table 137. Aspen Oss Corporation Information
    Table 138. Aspen Oss Description and Major Businesses
    Table 139. Aspen Oss Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 140. Aspen Oss Heparin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Aspen Oss Recent Development
    Table 142. King-friend Biochemical Pharmaceutical Corporation Information
    Table 143. King-friend Biochemical Pharmaceutical Description and Major Businesses
    Table 144. King-friend Biochemical Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 145. King-friend Biochemical Pharmaceutical Heparin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. King-friend Biochemical Pharmaceutical Recent Development
    Table 147. Bioibérica Corporation Information
    Table 148. Bioibérica Description and Major Businesses
    Table 149. Bioibérica Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 150. Bioibérica Heparin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Bioibérica Recent Development
    Table 152. Dongcheng Biochemicals Corporation Information
    Table 153. Dongcheng Biochemicals Description and Major Businesses
    Table 154. Dongcheng Biochemicals Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 155. Dongcheng Biochemicals Heparin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Dongcheng Biochemicals Recent Development
    Table 157. Jiulong Biochemicals Corporation Information
    Table 158. Jiulong Biochemicals Description and Major Businesses
    Table 159. Jiulong Biochemicals Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 160. Jiulong Biochemicals Heparin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. Jiulong Biochemicals Recent Development
    Table 162. Tiandong Corporation Information
    Table 163. Tiandong Description and Major Businesses
    Table 164. Tiandong Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 165. Tiandong Heparin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 166. Tiandong Recent Development
    Table 167. Xinbai Corporation Information
    Table 168. Xinbai Description and Major Businesses
    Table 169. Xinbai Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 170. Xinbai Heparin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 171. Xinbai Recent Development
    Table 172. Yino Pharma Corporation Information
    Table 173. Yino Pharma Description and Major Businesses
    Table 174. Yino Pharma Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 175. Yino Pharma Heparin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 176. Yino Pharma Recent Development
    Table 177. Deebio Corporation Information
    Table 178. Deebio Description and Major Businesses
    Table 179. Deebio Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 180. Deebio Heparin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 181. Deebio Recent Development
    Table 182. Key Raw Materials Lists
    Table 183. Raw Materials Key Suppliers Lists
    Table 184. Heparin Distributors List
    Table 185. Heparin Customers List
    Table 186. Heparin Market Trends
    Table 187. Heparin Market Drivers
    Table 188. Heparin Market Challenges
    Table 189. Heparin Market Restraints
    Table 190. Research Programs/Design for This Report
    Table 191. Key Data Information from Secondary Sources
    Table 192. Key Data Information from Primary Sources
List of Figures
    Figure 1. Heparin Product Picture
    Figure 2. Global Heparin Market Share by Type in 2021 & 2028
    Figure 3. Heparin Sodium Raw Material Drug Product Picture
    Figure 4. Heparin Calcium Raw Material Drug Product Picture
    Figure 5. Global Heparin Market Share by Application in 2021 & 2028
    Figure 6. Low Molecular Weight Heparin Preparation
    Figure 7. Standard Heparin Preparation
    Figure 8. Heparin Report Years Considered
    Figure 9. Global Heparin Capacity, Production and Utilization (2017-2028) & (B Units)
    Figure 10. Global Heparin Production Market Share by Region in Percentage: 2021 Versus 2028
    Figure 11. Global Heparin Production Market Share by Region (2017-2022)
    Figure 12. Global Heparin Production Market Share by Region (2023-2028)
    Figure 13. Heparin Production Growth Rate in North America (2017-2028) & (B Units)
    Figure 14. Heparin Production Growth Rate in Europe (2017-2028) & (B Units)
    Figure 15. Heparin Production Growth Rate in China (2017-2028) & (B Units)
    Figure 16. Heparin Production Growth Rate in Mexico (2017-2028) & (B Units)
    Figure 17. Global Heparin Sales 2017-2028 (B Units)
    Figure 18. Global Heparin Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 19. Global Heparin Revenue 2017-2028 (US$ Million)
    Figure 20. Global Heparin Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 21. Global Heparin Sales Market Share by Region (2017-2022)
    Figure 22. Global Heparin Sales Market Share by Region (2023-2028)
    Figure 23. North America Heparin Sales YoY (2017-2028) & (B Units)
    Figure 24. North America Heparin Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Europe Heparin Sales YoY (2017-2028) & (B Units)
    Figure 26. Europe Heparin Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Heparin Sales YoY (2017-2028) & (B Units)
    Figure 28. Asia-Pacific Heparin Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. Latin America Heparin Sales YoY (2017-2028) & (B Units)
    Figure 30. Latin America Heparin Revenue YoY (2017-2028) & (US$ Million)
    Figure 31. Middle East & Africa Heparin Sales YoY (2017-2028) & (B Units)
    Figure 32. Middle East & Africa Heparin Revenue YoY (2017-2028) & (US$ Million)
    Figure 33. The Heparin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 34. The Top 5 and 10 Largest Manufacturers of Heparin in the World: Market Share by Heparin Revenue in 2021
    Figure 35. Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 36. Global Heparin Sales Market Share by Type (2017-2028)
    Figure 37. Global Heparin Revenue Market Share by Type (2017-2028)
    Figure 38. Global Heparin Sales Market Share by Application (2017-2028)
    Figure 39. Global Heparin Revenue Market Share by Application (2017-2028)
    Figure 40. North America Heparin Sales Market Share by Type (2017-2028)
    Figure 41. North America Heparin Revenue Market Share by Type (2017-2028)
    Figure 42. North America Heparin Sales Market Share by Application (2017-2028)
    Figure 43. North America Heparin Revenue Market Share by Application (2017-2028)
    Figure 44. North America Heparin Sales Share by Country (2017-2028)
    Figure 45. North America Heparin Revenue Share by Country (2017-2028)
    Figure 46. U.S. Heparin Revenue (2017-2028) & (US$ Million)
    Figure 47. Canada Heparin Revenue (2017-2028) & (US$ Million)
    Figure 48. Europe Heparin Sales Market Share by Type (2017-2028)
    Figure 49. Europe Heparin Revenue Market Share by Type (2017-2028)
    Figure 50. Europe Heparin Sales Market Share by Application (2017-2028)
    Figure 51. Europe Heparin Revenue Market Share by Application (2017-2028)
    Figure 52. Europe Heparin Sales Share by Country (2017-2028)
    Figure 53. Europe Heparin Revenue Share by Country (2017-2028)
    Figure 54. Germany Heparin Revenue (2017-2028) & (US$ Million)
    Figure 55. France Heparin Revenue (2017-2028) & (US$ Million)
    Figure 56. U.K. Heparin Revenue (2017-2028) & (US$ Million)
    Figure 57. Italy Heparin Revenue (2017-2028) & (US$ Million)
    Figure 58. Russia Heparin Revenue (2017-2028) & (US$ Million)
    Figure 59. Asia Pacific Heparin Sales Market Share by Type (2017-2028)
    Figure 60. Asia Pacific Heparin Revenue Market Share by Type (2017-2028)
    Figure 61. Asia Pacific Heparin Sales Market Share by Application (2017-2028)
    Figure 62. Asia Pacific Heparin Revenue Market Share by Application (2017-2028)
    Figure 63. Asia Pacific Heparin Sales Share by Region (2017-2028)
    Figure 64. Asia Pacific Heparin Revenue Share by Region (2017-2028)
    Figure 65. China Heparin Revenue (2017-2028) & (US$ Million)
    Figure 66. Japan Heparin Revenue (2017-2028) & (US$ Million)
    Figure 67. South Korea Heparin Revenue (2017-2028) & (US$ Million)
    Figure 68. India Heparin Revenue (2017-2028) & (US$ Million)
    Figure 69. Australia Heparin Revenue (2017-2028) & (US$ Million)
    Figure 70. Taiwan Heparin Revenue (2017-2028) & (US$ Million)
    Figure 71. Indonesia Heparin Revenue (2017-2028) & (US$ Million)
    Figure 72. Thailand Heparin Revenue (2017-2028) & (US$ Million)
    Figure 73. Malaysia Heparin Revenue (2017-2028) & (US$ Million)
    Figure 74. Philippines Heparin Revenue (2017-2028) & (US$ Million)
    Figure 75. Latin America Heparin Sales Market Share by Type (2017-2028)
    Figure 76. Latin America Heparin Revenue Market Share by Type (2017-2028)
    Figure 77. Latin America Heparin Sales Market Share by Application (2017-2028)
    Figure 78. Latin America Heparin Revenue Market Share by Application (2017-2028)
    Figure 79. Latin America Heparin Sales Share by Country (2017-2028)
    Figure 80. Latin America Heparin Revenue Share by Country (2017-2028)
    Figure 81. Mexico Heparin Revenue (2017-2028) & (US$ Million)
    Figure 82. Brazil Heparin Revenue (2017-2028) & (US$ Million)
    Figure 83. Argentina Heparin Revenue (2017-2028) & (US$ Million)
    Figure 84. Middle East and Africa Heparin Sales Market Share by Type (2017-2028)
    Figure 85. Middle East and Africa Heparin Revenue Market Share by Type (2017-2028)
    Figure 86. Middle East and Africa Heparin Sales Market Share by Application (2017-2028)
    Figure 87. Middle East and Africa Heparin Revenue Market Share by Application (2017-2028)
    Figure 88. Middle East and Africa Heparin Sales Share by Country (2017-2028)
    Figure 89. Middle East and Africa Heparin Revenue Share by Country (2017-2028)
    Figure 90. Turkey Heparin Revenue (2017-2028) & (US$ Million)
    Figure 91. Saudi Arabia Heparin Revenue (2017-2028) & (US$ Million)
    Figure 92. U.A.E Heparin Revenue (2017-2028) & (US$ Million)
    Figure 93. Heparin Value Chain
    Figure 94. Heparin Production Process
    Figure 95. Channels of Distribution
    Figure 96. Distributors Profiles
    Figure 97. Bottom-up and Top-down Approaches for This Report
    Figure 98. Data Triangulation
    Figure 99. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SecuX Technology Inc
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Cardiac Rhythm Remote Monitoring Device Market Research Report 2022
Global Cardiac Rhythm Remote Monitoring Device Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-20H12415
Thu Nov 03 00:00:00 UTC 2022

Add to Cart

Global Cardiovascular Surgery Suture Thread Market Research Report 2022
Global Cardiovascular Surgery Suture Thread Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-16L11438
Thu Nov 03 00:00:00 UTC 2022

Add to Cart

Global ECG Monitoring Electrodes Market Research Report 2022
Global ECG Monitoring Electrodes Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-37J10807
Mon Oct 24 00:00:00 UTC 2022

Add to Cart

Add to Cart